Mamedica
Mamedica is a UK-based, CQC-registered medical cannabis clinic that uses a digital patient platform to prescribe cannabis-based medicines for chronic conditions such as chronic pain, anxiety, and PTSD, serving 15,000+ patients via direct-to-door delivery and subscription plans.
- Company typePrivate
- Founded2021
- HeadquartersLondon, United Kingdom
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Mamedica does
Mamedica, operating as Mamedica Limited, is a UK-based private medical cannabis clinic headquartered in London that prescribes cannabis-based medicines to patients suffering from chronic conditions including chronic pain, anxiety, depression, ADHD, PTSD, fibromyalgia, arthritis, insomnia, and back/neck pain. The company operates a direct-to-consumer digital healthcare platform centred on a patient-facing app (app.mamedica.com) where prospective patients complete an eligibility checker, book consultations with specialist doctors, and manage repeat prescriptions. It dispenses five product formats — dried flower, oils, vapes, pastilles, and capsules — through the separate Mamedica Dispensary e-commerce platform, with medication delivered directly to patients' homes and reported 24-hour fulfilment times.
The business model is built around recurring subscription revenue across four pricing tiers: Flex (£49 onboarding plus follow-up fees), Standard (£150/month with one free delivery and no clinic fees after 9 months), Access (£200/month with zero clinic fees for life for students, veterans, and benefit claimants), and Transfer (£75 for patients switching from other clinics). The company is CQC-registered (rated Good in November 2024) and operates from a single UK headquarters at 20 Midtown, London. As of 2025 it serves 15,000+ patients, is recognised in The Sunday Times 100 2026 as the UK's #8 fastest-growing private company, and employs 51-100 staff. It received £4.5 million in growth funding from US-based cannabis-focused VC Casa Verde in September 2025 to support platform improvements, patient base doubling, and European expansion.
Mamedica firmographics
Firmographics- Name
- Mamedica
- Legal name
- Mamedica Limited
- Website
- https://mamedica.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Mamedica is a UK-based, CQC-registered medical cannabis clinic that uses a digital patient platform to prescribe cannabis-based medicines for chronic conditions such as chronic pain, anxiety, and PTSD, serving 15,000+ patients via direct-to-door delivery and subscription plans.
- Ownership category
- akta.pro rank
Mamedica industry classification
Industry- Product category
- Medical Cannabis Clinic
- NAICS
- Offices of Physicians (62111), Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
- akta.pro secondary industries
- Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG), Cannabis Dispensary with On-Site Consumption Lounge (where permitted) (CRANAFAF)
Keywords
Where Mamedica is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Mamedica business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D
Revenue model
- Consultation Fees: Patients pay for initial consultations and follow-up appointments with specialist doctors. The Standard plan includes one free delivery per month.
- Treatment Plans: Ongoing revenue from prescribed cannabis-based medications delivered to patients monthly. Patients pay clinic fees for ongoing care, with no clinic fees after 9 months.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Lower monthly fees with flexibility for ongoing care patients |
| Subscription | Monthly | Best value long-term plan with one free delivery every month |
| Subscription | Monthly | Zero clinic fees for students, veterans, and benefit claimants |
| Subscription | One time/ perpetual license | Transfer pricing for patients switching from other clinics |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Mamedica product offering
Product offeringCore offering
Mamedica is a UK-based CQC-registered medical cannabis clinic that prescribes cannabis-based medications (flower, oils, vapes, pastilles, capsules) through specialist doctor consultations for chronic conditions such as chronic pain, anxiety, depression, ADHD, PTSD, fibromyalgia, arthritis, insomnia, and back/neck pain. Patients access care via an online eligibility checker and digital patient portal, with prescribed medication delivered directly to their door.
Product overview
Mamedica is a UK medical cannabis clinic offering a platform-based model combining digital healthcare services with cannabis-based medication products. The core offering includes specialist doctor consultations and a digital patient portal (app.mamedica.com) for eligibility checking, prescriptions, and ongoing treatment management. The company prescribes five distinct cannabis-based product forms: Flower (dried cannabis for vaporisation), Oils (cannabis extracts in oil form), Vapes (vapour delivery products), Pastilles (edible pastilles), and Capsules (gel capsules). These medications are delivered directly to patients via the Mamedica Dispensary. Pricing is structured across four subscription tiers: Flex (flexible payments), Standard (best value with free delivery), Access (zero clinic fees for students, veterans, and benefit claimants), and Transfer (for patients switching clinics).
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Cannabis Consultation Services Specialist doctor consultations to assess patient eligibility and prescribe cannabis-based medicines for conditions including anxiety, chronic pain, insomnia, and other chronic conditions.
- Flower (Dried Cannabis) Dried cannabis flower for vaporisation, offering fast symptom relief for medical cannabis patients.
- Cannabis Oils Cannabis extracts in oil form, ideal for precise, measured dosing for daily symptom management.
- Cannabis Vapes Discreet, fast-acting vapour delivery using high-quality cannabis extracts.
- Cannabis Pastilles Flavoured, dose-controlled edible cannabis products designed for daily relief.
- Cannabis Capsules Odourless, dose-controlled gel capsules designed for daily relief.
- Patient Portal Digital healthcare platform enabling patient login, eligibility checking, repeat prescriptions, and treatment management accessible via app.mamedica.com.
- Mamedica Dispensary Online dispensary for dispensing prescribed medical cannabis products to patients.
Quantifiable outcome
- 15,000+ patients served
- +2 more outcomes
Companies that use Mamedica
Customer profileNamed customers8 records
Segments2 records
Ideal customer profiles2 records
Mamedica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature3 records
Mamedica partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Mamedica competitors and assessment
Company assessmentDirect peers
- Alternaleaf: UK-based medical cannabis clinic with a digital-first patient onboarding and prescribing model targeting chronic conditions. Direct peer competing in the same online eligibility and consultation funnel.
- Sapphire Medical Clinics: UK-based medical cannabis clinic providing specialist doctor consultations and prescriptions across chronic pain, mental health, and other conditions. Direct peer offering the same regulated clinic + delivery model.
- CB1 Medical: UK medical cannabis clinic providing specialist consultations and prescriptions for chronic pain, mental health, and other qualifying conditions. Direct peer operating under the same CQC regulatory framework.
- Zerenia Clinic (formerly The Beeches Clinic): UK clinic offering specialist medical cannabis consultations and prescriptions for chronic conditions. Direct peer with CQC-registered prescribers and subscription-style clinic fees.
- Cannabis Access Clinics (Dr. David McDowell): UK clinic network offering specialist doctor consultations and medical cannabis prescriptions. Direct peer with overlapping patient indications and prescriber-led delivery model.
- LYPHE Group (formerly The Medical Cannabis Clinics): One of the largest UK medical cannabis clinic operators, with multiple specialist clinics across the UK offering similar doctor-led cannabis prescriptions for chronic conditions. Direct competitor in the same CQC-regulated clinical model.
- Curaleaf Clinic (formerly LYPHE Clinic): UK medical cannabis clinic operated by Curaleaf International, providing specialist consultations and cannabis prescriptions. Direct peer with overlapping prescriber base and product range.
Emerging players
- Celadon Pharmaceuticals: UK-listed pharmaceutical company developing cannabis-based medicines, with related medicinal-cannabis operations. Comparable category exposure though positioned upstream as a supplier rather than prescriber.
- Zana Medical: Smaller UK medical cannabis clinic providing specialist consultations and prescriptions. Emerging peer with partial overlap in chronic condition indications and digital onboarding.
Broad incumbents
- Emmac Life Sciences / Curaleaf International (parent): European medical cannabis operator with cultivation, distribution, and clinic assets including UK clinics. Comparable as a broader incumbent across the medical cannabis value chain.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Mamedica social profiles
Digital presenceMamedica compliance and trust
Trust signalCompliance1 record
Mamedica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mamedica leadership team
Management profileNumber of profiles
Profiles1 record
Mamedica funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mamedica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mamedica
What does Mamedica do?
Mamedica is a UK-based CQC-registered medical cannabis clinic that prescribes cannabis-based medications (flower, oils, vapes, pastilles, capsules) through specialist doctor consultations for chronic conditions such as chronic pain, anxiety, depression, ADHD, PTSD, fibromyalgia, arthritis, insomnia, and back/neck pain. Patients access care via an online eligibility checker and digital patient portal, with prescribed medication delivered directly to their door.
Is Mamedica a public or private company?
Mamedica is a private company. It is classified as venture growth investor backed and is currently operating.
When was Mamedica founded?
Mamedica was founded in 2021. It employs 51 to 100 people.
Where is Mamedica based?
Mamedica is headquartered in London, United Kingdom, in the Europe region.
How does Mamedica make money?
Two revenue lines are on record. Consultation Fees are the primary driver. The others are treatment Plans.
Who are Mamedica's main competitors?
Direct peers on record are Alternaleaf, Sapphire Medical Clinics, CB1 Medical, Zerenia Clinic (formerly The Beeches Clinic), Cannabis Access Clinics (Dr. David McDowell), LYPHE Group (formerly The Medical Cannabis Clinics) and Curaleaf Clinic (formerly LYPHE Clinic). Emerging players are Celadon Pharmaceuticals and Zana Medical. Emmac Life Sciences / Curaleaf International (parent) is listed as a broad incumbent.
Does Mamedica have an API?
No public API is recorded for Mamedica.
What industry is Mamedica in?
Mamedica's product category is Medical Cannabis Clinic. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAFAG, Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail). Its NAICS code is 62111 and its SIC code is 8000.